Susanne Rauch
Paul Ehrlich Str. 15
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.
Journal: The Journal of clinical investigation
Published: July 22, 2025
An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents.
Journal: Frontiers in immunology
Published: July 18, 2025
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice.
Journal: Molecular therapy. Nucleic acids
Published: June 28, 2024
Sequence-Optimized mRNA Vaccines Against Infectious Disease.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 30, 2024
Progress in vaccine development for infectious diseases-a Keystone Symposia report.
Journal: Annals of the New York Academy of Sciences
Published: April 06, 2023
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.
Journal: NPJ vaccines
Published: March 31, 2023
SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice.
Journal: European journal of immunology
Published: December 13, 2022
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.
Journal: Molecular therapy. Methods & clinical development
Published: August 04, 2022
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses.
Journal: Vaccines
Published: July 14, 2022
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models.
Journal: Nature communications
Published: April 22, 2022
Last Updated: 09/26/2026